Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Sunshine Biopharma (SBFM) Non Operating Income: 2015-2024

Historic Non Operating Income for Sunshine Biopharma (SBFM) over the last 10 years, with Dec 2024 value amounting to $443,147.

  • Sunshine Biopharma's Non Operating Income fell 47.20% to $65,355 in Q3 2025 from the same period last year, while for Sep 2025 it was -$33,399, marking a year-over-year decrease of 104.17%. This contributed to the annual value of $443,147 for FY2024, which is 34.29% down from last year.
  • Sunshine Biopharma's Non Operating Income amounted to $443,147 in FY2024, which was down 34.29% from $674,421 recorded in FY2023.
  • In the past 5 years, Sunshine Biopharma's Non Operating Income ranged from a high of $674,421 in FY2023 and a low of -$10.0 million during FY2021.
  • In the last 3 years, Sunshine Biopharma's Non Operating Income had a median value of $489,614 in 2022 and averaged $535,727.
  • As far as peak fluctuations go, Sunshine Biopharma's Non Operating Income slumped by 405.76% in 2020, and later soared by 104.90% in 2022.
  • Sunshine Biopharma's Non Operating Income (Yearly) stood at -$2.2 million in 2020, then tumbled by 352.89% to -$10.0 million in 2021, then surged by 104.90% to $489,614 in 2022, then surged by 37.75% to $674,421 in 2023, then crashed by 34.29% to $443,147 in 2024.